Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer's disease patients

被引：0
|
作者：
Chatanaka, Miyo K. [1 ]
Prassas, Ioannis [2 ]
Diamandis, Eleftherios P. [3 ]
机构：
[1] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[2] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada
[3] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
来源：
BMC MEDICINE | 2024年 / 22卷 / 01期
关键词：
Alzheimer's disease; Biomarker; Non-invasive; SMOC1; Neuropentraxin; Diagnostic test; Reference range;
D O I：
10.1186/s12916-024-03270-w
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this commentary, we address a paper published by Johnson et al. by assessing the robustness of their method to discover diagnostic biomarkers in Alzheimer's disease (AD). In addition, we examine how these newly discovered and previously discovered biomarkers, can play a role in assisting patients with AD and those at risk for developing AD, with an emphasis on the translational hurdles that accompany such discoveries.
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
    Huynh, Rose Ann
    Mohan, Chandra
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [22] Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: More to Come?
    Zetterberg, Henrik
    Blennow, Kaj
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 : S361 - S369
  • [23] Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly
    Randall, Catherine
    Mosconi, Lisa
    De Leon, Mony
    Glodzik, Lidia
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 1150 - 1173
  • [24] Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid
    Riekse, Robert G.
    Li, Ge
    Petrie, Eric C.
    Leverenz, James B.
    Vavrek, Darcy
    Vuletic, Simona
    Albers, John J.
    Montine, Thomas J.
    Lee, Virginia M. -Y.
    Lee, Michael
    Seubert, Peter
    Galasko, Douglas
    Schellenberg, Gerard D.
    Hazzard, William R.
    Peskind, Elaine R.
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 10 (04) : 399 - 406
  • [25] Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease
    Skogseth, Ragnhild
    Mulugeta, Ezra
    Ballard, Clive
    Rongve, Arvid
    Nore, Sabine
    Alves, Guido
    Aarsland, Dag
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (06) : 559 - 563
  • [26] Cerebrospinal fluid biomarkers for pathological processes in Alzheimer's disease
    Rosen, Christoffer
    Zetterberg, Henrik
    CURRENT OPINION IN PSYCHIATRY, 2013, 26 (03) : 276 - 282
  • [27] Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease
    Zetterberg, Henrik
    Lunn, Michael P.
    Herukka, Sanna-Kaisa
    BIOMARKERS IN MEDICINE, 2012, 6 (04) : 371 - 376
  • [28] A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium
    Somers, Charisse
    Struyfs, Hanne
    Goossens, Joery
    Niemantsverdriet, Ellis
    Luyckx, Jill
    De Roeck, Naomi
    De Roeck, Ellen
    De Vil, Bart
    Cras, Patrick
    Martin, Jean-Jacques
    De Deyn, Peter-Paul
    Bjerke, Maria
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (01) : 383 - 395
  • [29] Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer's disease
    Olsson, Martin
    Arlig, Johan
    Hedner, Jan
    Blennow, Kaj
    Zetterberg, Henrik
    SLEEP, 2018, 41 (05)
  • [30] Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
    Herukka, Sanna-Kaisa
    Simonsen, Anja Hviid
    Andreasen, Niels
    Baldeiras, Ines
    Bjerke, Maria
    Blennow, Kaj
    Engelborghs, Sebastiaan
    Frisoni, Giovanni B.
    Gabryelewicz, Tomasz
    Galluzzi, Samantha
    Handels, Ron
    Kramberger, Milica G.
    Kulczynska, Agnieszka
    Luis Molinuevo, Jose
    Mroczko, Barbara
    Nordberg, Agneta
    Oliveira, Catarina Resende
    Otto, Markus
    Rinne, Juha O.
    Rot, Uros
    Saka, Esen
    Soininen, Hilkka
    Struyfs, Hanne
    Suardi, Silvia
    Visser, Pieter Jelle
    Winblad, Bengt
    Zetterberg, Henrik
    Waldemar, Gunhild
    ALZHEIMERS & DEMENTIA, 2017, 13 (03) : 285 - 295
12345